-
Something wrong with this record ?
Aktuality z odborného tisku
Klinická onkologie.
2024 ;
37 (5) :
393-395.
Language Czech Country Czech Republic
Document type Overall
Persistent link
https://www.medvik.cz/link/bmc24020805
- MeSH
- Doxorubicin pharmacology therapeutic use MeSH
- Immune Checkpoint Inhibitors classification therapeutic use MeSH
- Ipilimumab pharmacology therapeutic use MeSH
- Leiomyosarcoma drug therapy MeSH
- Melanoma diagnosis drug therapy MeSH
- Stomach Neoplasms drug therapy MeSH
- Nivolumab pharmacology therapeutic use MeSH
- Antineoplastic Protocols MeSH
- Trabectedin pharmacology therapeutic use MeSH
- Publication type
- Overall MeSH
Formatted Contents
Preoperative chemoradiotherapy for resectable gastric cancer -- Doxorubicin–trabectedin with trabectedin maintenance in leiomyosarcoma -- Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma -- Corticosteroids for immune-related adverse events and checkpoint inhibitor efficacy – analysis of six clinical trials
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24020805
- 003
- CZ-PrNML
- 005
- 20250116123459.0
- 007
- ta
- 008
- 241112s2024 xr f 000 0|cze||
- 009
- PC
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a cze
- 044 __
- $a xr
- 245 00
- $a Aktuality z odborného tisku
- 505 0_
- $a Preoperative chemoradiotherapy for resectable gastric cancer -- Doxorubicin–trabectedin with trabectedin maintenance in leiomyosarcoma -- Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma -- Corticosteroids for immune-related adverse events and checkpoint inhibitor efficacy – analysis of six clinical trials
- 650 07
- $a nádory žaludku $x farmakoterapie $7 D013274 $2 czmesh
- 650 07
- $a protokoly protinádorové léčby $7 D024221 $2 czmesh
- 650 07
- $a doxorubicin $x farmakologie $x terapeutické užití $7 D004317 $2 czmesh
- 650 07
- $a trabektedin $x farmakologie $x terapeutické užití $7 D000077606 $2 czmesh
- 650 07
- $a leiomyosarkom $x farmakoterapie $7 D007890 $2 czmesh
- 650 07
- $a nivolumab $x farmakologie $x terapeutické užití $7 D000077594 $2 czmesh
- 650 07
- $a ipilimumab $x farmakologie $x terapeutické užití $7 D000074324 $2 czmesh
- 650 07
- $a melanom $x diagnóza $x farmakoterapie $7 D008545 $2 czmesh
- 650 07
- $a inhibitory kontrolních bodů $x klasifikace $x terapeutické užití $7 D000082082 $2 czmesh
- 655 07
- $a souhrny $7 D016424 $2 czmesh
- 773 0_
- $w MED00011030 $t Klinická onkologie $x 0862-495X $g Roč. 37, č. 5 (2024), s. 393-395
- 856 41
- $u https://www.prolekare.cz/casopisy/klinicka-onkologie/2024-5-2/aktuality-z-odborneho-tisku-138863 $y Meditorial
- 910 __
- $a ABA008 $b B 1665 $c 656 $y p $z 0
- 990 __
- $a 20241031 $b ABA008
- 991 __
- $a 20250116123453 $b ABA008
- 999 __
- $a ok $b bmc $g 2221561 $s 1232793
- BAS __
- $a 6
- BAS __
- $a PreBMC
- BMC __
- $a 2024 $b 37 $c 5 $d 393-395 $i 0862-495X $m Klinická onkologie $x MED00011030 $y 138863
- LZP __
- $c NLK193 $d 20241217 $b NLK111 $a Meditorial-20241031
